Why is there a supplement craze if they don’t even work?

Episode Summary

Executive Summary: The episode examines the booming U.S. supplement industry, how easy it is to manufacture and market a branded supplement, and why lax regulation lets products reach consumers with limited proof of safety or effectiveness. Through a failed attempt to make a Planet Money supplement, it shows how labels, claims, and ingredients can be highly flexible, while experts warn that supplements often deliver placebo more than proven benefit.

Main Topics: The supplement boom and consumer demand (Priority: 5/5): The show opens with the size and popularity of the U.S. supplement market, driven by wellness culture, influencer marketing, and a search for simple solutions to health and performance goals. How easy it is to make a supplement (Priority: 5/5): The hosts explore a supplement manufacturer’s process, discovering that custom or stock products can be developed and labeled quickly, with relatively low barriers to entry and flexible product positioning. Weak regulation and legal loopholes (Priority: 5/5): The episode explains how supplements occupy a regulatory gray zone between food and drugs, allowing companies to make structure/function claims without proving efficacy and often without pre-market safety proof. Historical consumer backlash against regulation (Priority: 4/5): Past FDA and congressional attempts to tighten supplement oversight repeatedly failed due to organized consumer and industry resistance, including lobbying, media campaigns, and political pressure. Examples of misleading or risky products (Priority: 5/5): The story of a memory supplement derived from a synthetic jellyfish protein illustrates how companies can use food-law workarounds, while other examples show supplements may contain unexpected or unsafe ingredients. Experts’ nuanced skepticism (Priority: 4/5): Nutrition and policy experts argue that most supplements are neither very effective nor especially harmful for many users, but quality varies widely and third-party certification is the best available safeguard.

Key Arguments: The supplement industry thrives because consumers want easy, repeatable fixes and are willing to buy products monthly, making the business highly profitable. It is relatively inexpensive and operationally simple to launch a supplement, especially by using stock formulas that can be relabeled. U.S. law largely permits supplement makers to market products without proving they work; claims like "supports metabolism" can imply benefits without substantiating them. Companies can sometimes bypass FDA scrutiny by first introducing a new ingredient as a food ingredient, then using that ingredient in a supplement. Many supplements contain variable, incomplete, or even absent amounts of the advertised ingredient, and some may include contaminants or unsafe doses. Despite the lack of strong evidence, supplements can still have value as placebos because they make people feel better and may encourage a sense of control. Third-party seals such as NSF or USP are among the few meaningful indicators that a product contains what it says and stays within safer levels.

Data Points: U.S. supplement industry size: $70 billion - Current scale of the American supplement market Share of Americans taking supplements: 75% - Reported prevalence of supplement use in the U.S. Number of supplement options: About 100,000 - Approximate variety of supplement products available Estimated market growth: Sales expected to double over the next 7 years - Projected future expansion of the supplement industry Increase since pre-pandemic: Around 50% - Supplement sales growth since before COVID-19 Smallest custom order estimate: About 8,333 bottles - Minimum production scale quoted by the manufacturer for a customized product Custom product cost per bottle: $4.50 to $7 - Estimated unit cost for the tailored supplement formula Estimated custom order total: Around $33,000 - Approximate cost of the smallest customized order Stock formula entry cost: $5,500 - Cheaper option for relabeling pre-existing formulas Manufacturer’s ready-made options: More than 800 - Number of stock gummies, pills, and powders available Sales of the jellyfish-based supplement: More than $165 million - Revenue accumulated between 2007 and 2015 Reported adverse effects: Chest pain, seizures, and strokes - Consumer reports associated with the jellyfish supplement Study on liver toxicity: 20% - Share of liver toxicity cases tied to herbal and dietary supplements in a 2017 study Rise in supplement-related liver failure: Eightfold - Increase over most of the last 30 years Consumer letters opposing regulation: More than 2 million - Public backlash to a 1966 FDA proposal for vitamin disclaimers Melanie Benish’s cited threshold: "reasonably be expected to be safe" - Standard required for new supplement ingredients under the law

Pivotal Quotes: ""Supplements live in this weird no man's land."" — Narrator: Description of the regulatory status of supplements between food and drugs ""supports metabolism"" — Frank Cantone: Example of the language used to make a health claim without explicitly saying a product burns fat ""What it says on the label is not what's in the package."" — Marion Nestle: Her warning that supplement contents may differ from advertised ingredients

Implications: For listeners, the episode is a warning to treat supplement claims skeptically and favor third-party testing. For industry, it shows how easy branding can outpace evidence. Future reform remains difficult unless consumer demand shifts or regulation tightens.